Cefixime and Nifedipine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefixime (cefixime) and Nifedipine (nifedipine). Common drug interactions include costochondritis among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cefixime and Nifedipine. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Nifedipine?

Nifedipine has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 53,459 Nifedipine users. Check the latest studies of Nifedipine.



On Jul, 18, 2026

54 people who take Cefixime and Nifedipine together, and have interactions are studied.

Cefixime and Nifedipine drug interactions.

What are the common drug interactions of Cefixime and Nifedipine, by gender? *:

female:

  1. Costochondritis (chest wall pain)
  2. Drug ineffective
  3. Hepatic enzyme increased
  4. Hepatomegaly (abnormal enlargement of the liver)
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Hypophagia (reduced food intake)
  7. Mouth ulceration (mouth ulcers)
  8. Pain in extremity
  9. Ulcer
  10. Vascular access complication

male:

  1. Diarrhoea
  2. Pneumonia
  3. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  4. Hyperbilirubinaemia (excess of bilirubin in the blood)
  5. Kidney transplant rejection
  6. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  7. Prostate cancer
  8. Renal atrophy (wasting of kidney)
  9. Renal tubular necrosis (death of kidney tubules)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

What are the common drug interactions of Cefixime and Nifedipine, by age (0-1 to 60+)? *:

0-1:

  1. Anaemia (lack of blood)
  2. Apgar score low
  3. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  4. Hypotonia (low muscle tone)
  5. Maternal condition nec affecting foetus (mother condition affecting baby non specific)
  6. Neonatal respiratory distress syndrome (a serious medical condition where a newborn baby's lungs cannot provide their body with enough oxygen)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arteriovenous fistula thrombosis (formation of a blood clot inside a blood vessel-av fistula)
  2. Arteritis (inflammation of the walls of arteries)
  3. Bladder dilatation
  4. Blood creatinine increased
  5. Blood lactate dehydrogenase increased
  6. Blood pressure fluctuation
  7. Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
  8. Hyperbilirubinaemia (excess of bilirubin in the blood)
  9. Kidney transplant rejection
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

40-49:

n/a

50-59:

  1. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
  2. Headache (pain in head)
  3. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  4. Mucosal inflammation (infection of mucous membrane)
  5. Nausea (feeling of having an urge to vomit)
  6. Neutropenia (an abnormally low number of neutrophils)
  7. Pneumonia
  8. Poor peripheral circulation
  9. Respiratory failure (inadequate gas exchange by the respiratory system)
  10. Skin discolouration (change of skin colour)

60+:

  1. Diarrhoea
  2. Pneumonia
  3. Lung infection
  4. Vascular access complication
  5. Intussusception
  6. Prostate cancer

What are the existing conditions these people have? *

  1. Behcet's Syndrome (involves inflammation of the blood vessels): 36 people, 66.67%
  2. Polychondritis (progressive inflammation of cartilage and other connective tissue): 5 people, 9.26%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 9.26%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and Nifedipine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefixime and Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nifedipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefixime and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nifedipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefixime and nifedipine (the active ingredients of Cefixime and Nifedipine, respectively), and Cefixime and Nifedipine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: